Vivos Therapeutics Inc (NASDAQ:VVOS) does about 206.55K shares in volume on a normal day but saw 244276 shares change hands in the recent trading day. The company now has a market cap of 23.26M USD. Its current market price is $4.81, marking a decrease of -6.05% compared to the previous close of $5.12. The 52 week high reached by this stock is $12.83 whilst the lowest price level in 52 weeks is $1.91.
Vivos Therapeutics Inc (VVOS) has a 20-day trading average at $4.32 and the current price is -62.51% off the 52-week high compared with 151.83% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.42 and its 200-day simple moving average is $2.88. If we look at the stock’s price movements over the week, volatility stands at 14.47%, which decreases to 12.17% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 65.76 to suggest the stock is neutral.
The consensus objective for the share price is $6.30, suggesting that the stock has a potential upside of 23.65% over the period.
The current price level is 11.19%, 40.59%, and 66.92% away from its SMA20, SMA50, and SMA200 respectively, with the VVOS price moving below the 50-day SMA on current market day. Vivos Therapeutics Inc (VVOS) stock is down -0.61% over the week and 52.19% over the past month. Its price is -60.85% year-to-date and -57.02% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.43 and -1.79 for whole year. Expected sales for next quarter are $4.1M, which analysts say will come at $15.2M for the current fiscal year and next year at $19.16M. In addition, estimates put the company’s current quarterly revenue at an average of $3.89M.
To reach the target analysts have set, the stock logically needs to grow 23.65 percent from here.
The company has a return on investment of -142.45% and return on equity of -325.98%. The beta has a value of 7.52. Price to book ratio is 2.99 and price to sales ratio is 1.60.
